Trials / Sponsors / jiangjingting
jiangjingting
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma Lymphoma, B Cell | Phase 4 | 2016-12-01 |